Airline Pilot Central Forums - Vaccine Development Summary

Airline Pilot Central Forums (https://www.airlinepilotforums.com/)

- COVID19 (https://www.airlinepilotforums.com/covid19/)

- - Vaccine Development Summary (https://www.airlinepilotforums.com/covid19/130375-vaccine-development-summary.html)

Quote:

Originally Posted by rickair7777 (Post 3288915)

Remember the trials? Double blind with control groups?

The controls accounted for any *effective* existing natural immunity, whether it was genetic, acquired from a previous coronavirus, or from covid-19.

The vaccines provided near-perfect protection against severe covid COMPARED TO THE CONTROLS. Plausible that some of that benefit was due to existing natural immunity + vaccine, but obviously existing natural immunity alone was not enough to get the death rate low enough for society in general to be cool with it.

I’m not sure any likely amount of immunity will get the death rate low enough for society in general ‘to be cool with it.’ Too many people apparently think they will live forever…

J&J trials reports 94% efficacy against severe covid with booster 2 months after first shot...

https://www.reuters.com/business/hea...94-2021-09-21/

I'll note the J&J is the same vaccine that is no longer recommended by our company physician.

Current guidance is to not get the Pfizer or Moderna if you followed the original advice and jabbed with the JnJ.

So this is a bit of a pickle, if the booster becomes mandatory.

As there is literally ZERO incentive for different pharmaceutical companies to test cross-vaccinations, one wonders where the SCIENCE (blessed by our science) will go with this one.

Quote:

Originally Posted by DeltaboundRedux (Post 3304650)

The fed can, and probably should, do trials on mixing and matching the vaccines. It might even work better that way.

Sweden & Denmark suspend use of moderna for under-30's, will use pfizer instead. Due to rare myocarditis and pericarditis events in young men(previouily identified in other countries).

https://www.reuters.com/business/hea...ts-2021-10-06/

Quote:

Originally Posted by rickair7777 (Post 3305169)

The Finns have jumped on to that train too:

Quote:

Finland announced on Thursday it will pause distribution of the Moderna COVID-19 vaccine to younger men, saying the small risk of heart inflammation exceeds the risk of contracting COVID-19 for that demographic.

The study, which found that men under 30 had a "slightly higher risk than others of developing myocarditis" after receiving the Moderna vaccine, is scheduled to be published within a couple of weeks. Mika Salminen, the Finnish health institute's director, said Finland will give younger men the Pfizer vaccine in the meantime, according to Reuters.

WHAT DELAYED THE LIFESAVING COVID-19 ANTIVIRAL PILL?

Moderna said the incidents "are typically mild cases and individuals tend to recover within a short time following standard treatment and rest."

"The risk of myocarditis is substantially increased for those who contract COVID-19, and vaccination is the best way to protect against this," the company added.

On Wednesday, Swedish and Danish health officials announced they would pause the use of the Moderna vaccine for all young adults and children, citing the same unpublished study as Finland, the report added.

Myocarditis is the inflammation of the heart muscle, with symptoms including chest pain, shortness of breath, and feelings of having an abnormal heartbeat. The inflammation typically occurs a few days after the second COVID-19vaccine injection. Despite this possibility, experts at the Centers for Disease Control and Prevention say the benefits of getting vaccinated against COVID-19 outweigh the risks.

mRNA boosters found to have best efficacy, even for those who the J&J shot initially...

https://www.npr.org/sections/health-...zer-works-best

FDA advisory board backs Moderna boosters unanimously (for elderly, at risk, occupational exposure).

They stated that the data wasn't especially compelling, but trending there :confused:

https://www.wsj.com/articles/fda-adv...w_article_pos4